Hepatectomy With or Without the Thoraco-abdominal Approach

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

744 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-01-01

Study Completion Date

2015-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The performance of hepatectomy for liver tumors using the thoraco-abdominal approach (TAA) versus the abdominal approach (AA) is still debated.

The aim of the study is the analysis of the perioperative outcome of patients operated with or without the TAA for liver tumors.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Resection for Multiple Hepatocellular Carcinomas (HCC)

NCT01387061

Hepatocellular Carcinoma Multiple Tumors Cirrhosis

COMPLETED NA

Multidisciplinary Management of HCC in Elderly Patients

NCT03875417

HCC Quality of Life

COMPLETED

Hepatectomy Versus Hepatectomy With Lymphadenectomy in Hepatocellular Carcinoma

NCT02031952

Hepatocellular Carcinoma

COMPLETED NA

Open vs Laparoscopic Liver Surgery for Colorectal Liver Metastases

NCT02727179

Colorectal Liver Metastasis Laparoscopic Liver Resection

COMPLETED NA

Open Versus Laparoscopic Ablation of Liver Malignancies

NCT06304766

Hepatocellular Carcinoma Cholangiocarcinoma Liver Metastases

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The prospectively maintained database was queried. A 1:1 propensity score-matched analysis was applied. Among 744 patients, 246 undergoing hepatectomy with TAA and 246 undergoing hepatectomy with AA were compared. These patients were matched for baseline characteristics, underlying liver disease, comorbidity, tumor features, and extent of the resection. The rates of morbidity and mortality were the study endpoints.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surgery Liver Tumors Hepatectomy Liver Resection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TAA

Thoraco-Abdominal Approach: those patients with liver tumors operated with the thoracic-abdominal approach

Hepatectomy

Intervention Type PROCEDURE

Surgery for liver tumors is the removal of a part of the liver affected by a tumor.

AA

Abdominal Approach: those patients with liver tumors operated with the abdominal approach (without the thoracotomy)

Hepatectomy

Intervention Type PROCEDURE

Surgery for liver tumors is the removal of a part of the liver affected by a tumor.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hepatectomy

Surgery for liver tumors is the removal of a part of the liver affected by a tumor.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

hepatic resection; liver resection; liver surgery

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* First liver surgery;
* Any type of malignant liver tumor, including hepatocellular carcinoma on cirrhosis.

Exclusion Criteria

* Previous history of liver surgery;
* Any type of benign liver tumor;
* Incomplete clinical, surgical, pathological or postoperative data;
* Patients treated with radiofrequency ablation alone or in combination with surgery were also excluded.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No